Do you have experience in health economics and payer evidence, and a strong drive to demonstrate and communicate the value of evidence-based medicine? Are you in search of a vibrant workplace where your skills can create a substantial difference? Are you prepared to contribute to the growth of a business in a region with tremendous growth opportunities? If your answer is yes to these questions, we encourage you to read on and submit your application today for Health Economics Senior Manager role!

At Novo Nordisk, we want to make a difference. Novo Nordisk is a global healthcare company with 100 years of innovation and supervision in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases. Headquartered in Denmark, Novo Nordisk employs over 60,000 people in 80 countries, and markets its products in more than 170 countries.

About the department
Region APAC was established in 2020 and it is one of the 7 Regions of International Operations. Our region covers 3000+ employees and 20 countries, including 7 elevated affiliates (Australia, India, Iran, Indonesia, Korea, Pakistan, Thailand) and 1 business area covering South-East Asian markets (BASEA).
You will be part of the APAC Commercial Affairs and Strategy department, a diverse and energetic team of 20 commercial colleagues. We believe we have a great working culture and a clear purpose to defeat serious chronic diseases.

We are looking for a Health Economics professional who shares our purpose and is passionate about applying and sharing her/his expertise in payer evidence, to unlock access to our medicine for patients in APAC.

So, if like us, you strive to drive change and increase access to health and care for patients in APAC, then we\xe2\x80\x99re looking forward to talking to you and potentially you will have a life-changing career in Novo Nordisk.

The position

This position will report to the Senior Director of Market Access and Public Affairs APAC, with a dotted line report to the Access Directors.
Your role will focus on:

• Assist market access preparedness for pipeline products.
• Leveraging Health Economics and Outcomes Research to demonstrate and communicate the value of the Novo Nordisk in-line brands.
• Generating evidence through among others systematic literature review, economic evaluation, and database studies.
• Monitoring the Health Technology Assessment (HTA) bodies across the designated affiliates.
• Raising Payer evidence awareness and capabilities within the regional organization.

Qualifications

• M.Sc. or Ph.D. degree within health economics, public health, epidemiology, pharmacy or similar.
• At least 5 years of experience in Pharmacoeconomics from an affiliate, regional or headquarter role or from a consultancy.
• Experience in the development and execution of HEOR studies, payer evidence strategies, and reimbursement submissions to payers and HTA bodies.
• Strong project and stakeholder management skills are required.
• Business acumen with the ability to anchor market access activities towards patient access and business goals. Fluent in written and spoken English.

Working at Novo Nordisk

At Novo Nordisk, we don\xe2\x80\x99t wait for change. We drive it. We\xe2\x80\x99re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing, and sales \xe2\x80\x93 we\xe2\x80\x99re all working to move the needle on patient care.

Contact
Upload your CV to our online career page (click on Apply and follow the instructions).

Deadline
5 Jan 2024

We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we\xe2\x80\x99re life changing.

#LI-AMS1

Novo Nordisk